Using low-level laser therapy to treat menopause-related genitourinary symptoms
Assessing the Efficacy of Low-Level Laser Therapy in Alleviating Genitourinary Symptoms of Menopause
This study is testing if low-level laser therapy can help women over 45 feel better by reducing menopause-related genitourinary symptoms.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 28 (estimated) |
| Ages | 45 Years to 85 Years |
| Sex | Female |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei City) |
| Trial ID | NCT06074120 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the feasibility and potential efficacy of low-level laser therapy (LLLT) in alleviating genitourinary symptoms associated with menopause in women aged 45 and older. Participants will be recruited from a gynecology clinic and will receive LLLT sessions once a week for eight weeks. The therapy is designed to stimulate tissue regeneration and improve blood circulation in the genitourinary area. Baseline assessments will be conducted to measure the severity of symptoms and quality of life before treatment begins.
Who should consider this trial
Good fit: Ideal candidates for this study are menopausal women aged 45 and older experiencing genitourinary symptoms such as vaginal dryness and urinary incontinence.
Not a fit: Patients with advanced pelvic organ prolapse or a history of pelvic malignancy may not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could provide a non-invasive treatment option for menopausal women suffering from genitourinary symptoms.
How similar studies have performed: While this approach is relatively novel, preliminary studies on low-level laser therapy for similar conditions have shown promising results.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Menopause women * With genitourinary symptoms of menopause Exclusion Criteria: * Acute or chronic infection of the genitourinary tract * Advanced pelvic organ prolapse (\>= stage 2 on pelvic organ prolapse quantification system) * History of pelvic malignancy * Unstable blood pressure * Fever * Abnormal sensory nerve * Abnormal coagulation
Where this trial is running
Taipei City
- National Taiwan University Hospital — Taipei City, Taiwan (Recruiting)
Study contacts
- Principal investigator: Pei-chi Wu, MD. — National Taiwan University Hospital
- Study coordinator: Pei-chi Wu, MD.
- Email: peggywu0707@hotmail.com
- Phone: 0972651989
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.